- SPOP mutation drives prostate neoplasia without stabilizing oncogenic transcription factor ERG. Journal of Clinical Investigation. 2018 Academic Article GET IT
Co-clinical Analysis of a Genetically Engineered Mouse Model and Human Prostate Cancer Reveals Significance of NKX3.1 Expression for Response to 5α-reductase Inhibition.
Times cited: 2
- Identification of novel prostate cancer drivers using RegNetDriver: A framework for integration of genetic and epigenetic alterations with tissue-specific regulatory network. Genome Biology. 2017 Academic Article GET IT
SPOP Mutation Drives Prostate Tumorigenesis In Vivo through Coordinate Regulation of PI3K/mTOR and AR Signaling.
Times cited: 17
SPOP mutation leads to genomic instability in prostate cancer.
Times cited: 30